XIGA MET XR 5 500MG TABLET

Xiga Met XR 5 500mg Tablet is a combination medication that contains two active ingredients: dapagliflozin and metformin. It is primarily prescribed for the management of type 2 diabetes mellitus in adults. Dapagliflozin works by reducing the reabsorption of glucose in the kidneys, promoting its excretion through urine. Metformin helps to decrease the production of glucose in the liver and improves insulin sensitivity in the body. The combination of these two medications can help control blood sugar levels and improve glycemic control in patients with type 2 diabetes.

Side Effects:

1. Urinary Tract Infections: Dapagliflozin, one of the components in Xiga Met XR 5 500mg Tablet, may increase the risk of urinary tract infections. Symptoms may include frequent urination, burning sensation while urinating, and lower abdominal pain. If these symptoms occur, it is recommended to seek medical attention.
2. Hypoglycemia: Metformin, another component in the medication, may cause hypoglycemia (low blood sugar levels) when used in combination with other blood sugar-lowering medications. Symptoms of hypoglycemia include sweating, trembling, dizziness, confusion, and weakness. Prompt treatment with glucose or sugary foods is required in such cases.
3. Gastrointestinal Upset: Common side effects of Xiga Met XR 5 500mg Tablet include nausea, diarrhea, abdominal pain, and flatulence. These symptoms are usually mild and temporary but if they persist or worsen, it is advisable to consult a healthcare professional.

When Not to Use:

1. Type 1 Diabetes: Xiga Met XR 5 500mg Tablet is not indicated for the treatment of type 1 diabetes.
2. Diabetic Ketoacidosis: This medication should not be used in patients with diabetic ketoacidosis, a serious complication of diabetes characterized by high blood sugar, ketones in the urine, and acidosis. Immediate medical attention is required in such cases.
3. Severe Renal Impairment: Xiga Met XR 5 500mg Tablet should be avoided in patients with severe renal impairment or end-stage renal disease as it may further compromise kidney function.
4. Allergy: Individuals with a known hypersensitivity or allergy to dapagliflozin, metformin, or any other ingredients in the medication should not use Xiga Met XR 5 500mg Tablet.

It is crucial to consult a healthcare professional, such as a physician or endocrinologist, before initiating Xiga Met XR 5 500mg Tablet. They can evaluate the patient’s medical history and provide appropriate guidance regarding the dosage and potential interactions with other medications. Regular monitoring of blood glucose levels and kidney function is essential during treatment with this medication.